Abduljelil Ajala

ORCID, self-asserted

ORCID 0000-0002-9823-8847

Publications

Citations

253

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

27 works in the graph, newest first.

Method validation, molecular docking and assessment of the prevalence of RHESUS alloantibodies among non-pregnant females in Ali Kazaure, Jos, Plateau State
2026Gene ReportsJournalSenior author0 citations10.1016/j.genrep.2026.102532
In-silico design and evaluation of quinoline-dione derivatives as Mycobacterium tuberculosis DprE1 inhibitors
2025Discover MoleculesJournalOpen accessCorresponding8 citations10.1007/s44345-025-00027-7
Therapeutic exploration potential of adenosine receptor antagonists through pharmacophore ligand-based modelling and pharmacokinetics studies against Parkinson disease
2025In Silico PharmacologyJournalOpen accessFirst authorCorresponding6 citations10.1007/s40203-025-00305-9
In-silico screening, pharmacokinetic evaluation, DFT study, and molecular dynamic simulation as approaches for the identification of acetamide and acetic acid derivatives as potential antisickling agents targeting Hba protein
2025Discover Chemistry.Book ChapterOpen access3 citations10.1007/s44371-025-00136-9
A comprehensive review of the innovations, applications, and future prospects of nanomaterials in water treatment
2025Nano-Structures & Nano-ObjectsJournalCorresponding3 citations10.1016/j.nanoso.2025.101583
Computational techniques for analyzing and interpreting some quinoxaline-containing molecules as possible anti-schistosomal agents using docking, pharmacokinetics, drug-likeness, QSAR, and molecular dynamics evaluation
2025In Silico Research in BiomedicineJournalOpen access1 citations10.1016/j.insi.2025.100024
In silico design of 3-methyl-3H-naphtho[1,2,3-de]quinoline-2,7-dione inhibitors against tuberculosis via docking and dynamics simulation techniques and pharmacokinetic evaluation
2025ASPET DiscoveryJournalOpen accessCorresponding0 citations10.1016/j.aspetd.2025.100007
Computer-aided design process of possible antisickling agents using molecular docking, pharmacokinetic assessment, homology modeling, and molecular dynamic studies targeting Hba protein
2025In Silico PharmacologyJournalOpen access0 citations10.1007/s40203-025-00424-3
Computational evaluation of the inhibitory potential of some urea, thiourea, and selenourea derivatives of diselenides against leishmaniasis: 2D-QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation
2024Journal of Molecular StructureJournal48 citations10.1016/j.molstruc.2023.137473
In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and molecular dynamics investigations
2024BMC ChemistryJournalOpen access32 citations10.1186/s13065-024-01248-6
Virtual screening and pharmacokinetics analysis of inhibitors against tuberculosis: Structure and ligand-based approach
2024Scientific AfricanJournalOpen accessCorresponding11 citations10.1016/j.sciaf.2024.e02085
Genetic function algorithm (GFA) based QSAR, molecular design, and ADMET screening to assess the antimalarial potential of Amodiaquine derivatives
2024The MicrobeJournalOpen access7 citations10.1016/j.microb.2024.100208
Molecular Docking and Drug Kinetics Assessment for Structure-Based Drug Design of New Piperazine-Containing Hydrazone Derivatives as Effective Alzheimer Inhibitors
2024Journal of Biochemistry Microbiology and BiotechnologyJournalOpen access4 citations10.54987/jobimb.v12i2.1016
An Evaluation of the Pharmacokinetics and Virtual Screening of Highly Effective Hybrid Compounds for Alzheimer's Disease
2024Journal of Environmental Bioremediation and ToxicologyJournalOpen access0 citations10.54987/jebat.v7i2.1046
In-silico screening and ADMET evaluation of therapeutic MAO-B inhibitors against Parkinson disease
2023Intelligent PharmacyJournalOpen accessFirst authorCorresponding16 citations10.1016/j.ipha.2023.12.008
QSAR, simulation techniques, and ADMET/pharmacokinetics assessment of a set of compounds that target MAO-B as anti-Alzheimer agent
2023Future Journal of Pharmaceutical SciencesJournalOpen accessFirst authorCorresponding18 citations10.1186/s43094-022-00452-2
Virtual screening, molecular docking simulation and ADMET prediction of some selected natural products as potential inhibitors of NLRP3 inflammasomes as drug candidates for Alzheimer disease
2023Biocatalysis and Agricultural BiotechnologyJournalFirst authorCorresponding15 citations10.1016/j.bcab.2023.102615
QSAR, molecular docking, and molecular designs of some anti-epilepsy compounds
2023Intelligent PharmacyJournalOpen access10 citations10.1016/j.ipha.2023.11.011
Natural product inhibitors as potential drug candidates against Alzheimer's disease: Structural-based drug design, molecular docking, molecular dynamic simulation experiments, and ADMET predictions
2023Journal of the Indian Chemical SocietyJournalFirst authorCorresponding8 citations10.1016/j.jics.2023.100977
In silico screening of potential Tumor necrosis factor alpha (TNF-α) inhibitors through molecular modeling, molecular docking, and pharmacokinetics evaluations
2023Scientific AfricanJournalOpen accessSenior author8 citations10.1016/j.sciaf.2023.e01830
QSAR application of natural therapeutics inhibitors against Alzheimer's disease through in-silico virtual-screening, docking-simulation, molecular dynamics, and pharmacokinetic prediction analysis
2023Intelligent PharmacyJournalOpen accessFirst authorCorresponding7 citations10.1016/j.ipha.2023.12.004
In-silico studies of some potent hybrid compounds against Alzheimer's disease through virtual screening, simulation techniques, and pharmacokinetic endowment
2023Biocatalysis and Agricultural BiotechnologyJournalFirst authorCorresponding1 citations10.1016/j.bcab.2023.102941
Structure-Based Drug Design of Novel Piperazine Containing Hydrazone Derivatives as Potent Alzheimer Inhibitors: Molecular Docking and Drug Kinetics Evaluation
2022Brain DisordersJournalOpen accessFirst authorCorresponding18 citations10.1016/j.dscb.2022.100041
2D QSAR, design, docking study and ADMET of some N-aryl derivatives concerning inhibitory activity against Alzheimer disease
2022Future Journal of Pharmaceutical SciencesJournalOpen accessFirst authorCorresponding13 citations10.1186/s43094-022-00420-w
QSAR, Molecular Docking, Dynamic Simulation and Kinetic Study of Monoamine Oxidase B Inhibitors as Anti-Alzheimer Agent
2022Chemistry AfricaJournalFirst authorCorresponding7 citations10.1007/s42250-022-00561-8
Chemometric Study, Homology Modeling of G Protein-Coupled Bile Acids Receptor (GPBAR_HUMAN) of Type-2 Diabetes Mellitus, Virtual Screening Evaluation, Drug-Likeness and ADME Prediction for Newly Designed Compounds
2022Macromolecular ResearchJournal5 citations10.1007/s13233-022-0071-3
Computational and pharmacokinetics studies of 1,3-dimethylbenzimidazolinone analogues of new proposed agent against Alzheimer's disease
2022Beni-Suef University Journal of Basic and Applied SciencesJournalOpen accessFirst authorCorresponding4 citations10.1186/s43088-022-00231-1